Cameco shares slide as uranium names pull back ahead of upcoming Q1 results

Cameco Corporation (CCJ) is down 3.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with a broader pullback in uranium-linked equities and short-term de-risking ahead of Cameco’s next earnings update. With uranium pricing having been volatile and range-bound at times, miners can swing on sentiment even without company-specific headlines.

Details:

Cameco scheduled its first-quarter 2026 results and conference call for May 5, 2026, putting the stock in a “wait for the print” window where positioning often gets reduced.

Uranium spot-price data tracked by widely followed market datasets has shown meaningful year-over-year strength, but shorter-term pricing can still consolidate, which can pressure mining equities on down days.

This could be because investors rotated out of higher-beta uranium miners after recent sector strength, especially into the weekend and just ahead of the company’s results.

Absent a specific Cameco operational update today, the decline appears more sentiment-driven than tied to a single discrete corporate event.

Sources:

Cameco, YCharts, Sprott

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive CCJ Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CCJ Hedge Fund Activity

We have seen 481 institutional investors add shares of $CCJ stock to their portfolio, and 429 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 2,212,569 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $202,427,937
FIL LTD removed 2,094,018 shares (-19.4%) from their portfolio in Q4 2025, for an estimated $191,581,706
CITIGROUP INC removed 1,781,746 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $163,011,941
MARSHALL WACE, LLP added 1,729,454 shares (+7481.3%) to their portfolio in Q4 2025, for an estimated $158,227,746
ALLIANCEBERNSTEIN L.P. removed 1,638,428 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $149,899,777
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 1,556,157 shares (+12.0%) to their portfolio in Q4 2025, for an estimated $142,372,803
MIZUHO MARKETS CAYMAN LP removed 1,530,760 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $140,049,232

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$CCJ Congressional Stock Trading

Members of Congress have traded $CCJ stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CCJ stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/09, 12/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$CCJ Analyst Ratings

Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 04/20/2026
GLJ Research issued a "Buy" rating on 02/18/2026
RBC Capital issued a "Outperform" rating on 11/13/2025

To track analyst ratings and price targets for $CCJ, check out Quiver Quantitative's $CCJ forecast page.

$CCJ Price Targets

Multiple analysts have issued price targets for $CCJ recently. We have seen 3 analysts offer price targets for $CCJ in the last 6 months, with a median target of $160.0.

Here are some recent targets:

Gordon L. Johnson from GLJ Research set a target price of $171.2 on 02/18/2026
Andrew D. Wong from RBC Capital set a target price of $160.0 on 02/17/2026
George Eadie from UBS set a target price of $140.0 on 11/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.